{"id":16226,"date":"2013-02-05T19:30:00","date_gmt":"2013-02-05T18:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/la-farmaceutica-in-italia-da-bancomat-a-risorsa-per-la-crescita-confronto-sul-futuro-del-farmaco-allambasciata-usa\/"},"modified":"2013-02-05T19:30:00","modified_gmt":"2013-02-05T18:30:00","slug":"la-farmaceutica-in-italia-da-bancomat-a-risorsa-per-la-crescita-confronto-sul-futuro-del-farmaco-allambasciata-usa","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/la-farmaceutica-in-italia-da-bancomat-a-risorsa-per-la-crescita-confronto-sul-futuro-del-farmaco-allambasciata-usa\/","title":{"rendered":"Pharmaceuticals in Italy: from ATM to resource for growth. Discussion on the future of the drug at the US Embassy"},"content":{"rendered":"<p style=\"text-align: left\">&nbsp;<a href=\"http:\/\/www.sanita.ilsole24ore.com\/art\/imprese\/2013-02-05\/farmaceutica-italia-bancomat-risorsa-084053.php?uuid=AbDF3HRH\" target=\"_blank\" rel=\"noopener\"><span style=\"font-size: xx-large\"><strong><span style=\"font-family: Verdana\">Pharmaceuticals in Italy: from ATM to resource for growth. Discussion on the future of the drug at the US Embassy<\/span><\/strong><\/span><\/a><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><b style=\"mso-bidi-font-weight: normal\"><span style=\"line-height: 115%; font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: #c00000; font-size: 18pt; mso-font-kerning: 18.0pt\">Medicines. US industries to Italy: \u201cNo more spot interventions. We need stability to get out of the crisis\u201d<\/p>\n<p><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-outline-level: 3\"><b><i><span style=\"font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\">No more &#039;spot&#039; interventions in the sector, no institutional fragmentation, promoting a policy of innovation and patents. And then adapt payment times to EU standards and promote the Italian system abroad. Here are the proposals of the American pharmaceutical industries to get out of the crisis. <a target=\"_blank\" href=\"http:\/\/www.quotidianosanita.it\/allegati\/allegato4601446.pdf\" rel=\"noopener\"><span style=\"color: blue\">SEE THE IAPG WORKING PAPER<\/span><\/a><\/span><\/i><\/b><b><span style=\"font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: black; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\"><\/p>\n<p><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto\"><b><span style=\"font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: #c10c05; font-size: 8.5pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: IT\">05 FEB<\/span><\/b><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #333333; font-size: 10.5pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\"> &#8211; <\/span><font size=\"3\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\">Greater attractiveness of the Italian system and start of a stable and constructive dialogue between the institutions, the political world and the representatives of the pharmaceutical industry. These and not only the priorities discussed during the conference &quot;The role and future of the American pharmaceutical industry in Italy&quot;, hosted in Rome by the Ambassador of the United States, David Thorne, and in the presence of the Minister of Health Renato Balduzzi, the Undersecretary of the Ministry of Economic Development Claudio De Vincenti, the Director General of the Italian Medicines Agency Luca Pani and many representatives of the political and business world.<\/p>\n<p> The pharmaceutical sector is a strategic sector for the economy of Western countries. <span style=\"color: #333333\">(<a target=\"_blank\" href=\"http:\/\/www.quotidianosanita.it\/allegati\/allegato4601446.pdf\" rel=\"noopener\"><span style=\"color: blue\">SEE THE IAPG WORKING PAPER<\/span><\/a>) <\/span>Italy, in fact, represents the second largest sector for US investors both in terms of turnover (20%) and employment (14%).<\/p>\n<p> A sector in which innovation and patent protection are the foundations for competing. With a turnover exceeding 5 billion Euros, over 13,000 employees (about 5,000 in R&amp;D<\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp;La farmaceutica in Italia: da bancomat a risorsa per la crescita. Confronto sul futuro del farmaco all&#8217;Ambasciata Usa Farmaci. Industrie Usa all&rsquo;Italia: &ldquo;Basta interventi spot. Serve stabilit&agrave; per uscire dalla crisi&rdquo; Basta interventi &lsquo;spot&rsquo; sul settore, no alla frammentazione istituzionale, promuovere una politica dell&rsquo;innovazione e del brevetto. E poi adeguare i tempi di pagamento agli &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-16226","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16226","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=16226"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16226\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=16226"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=16226"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=16226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}